Table 1.

Percentage of immunophenotype of CV-MSCs with HP and CV-MSCs with non-HP.

	CD29	CD44	CD73	CD90	CD105	CD31	CD34	CD45
HP	99.6 ± 0.08%	99.0 ± 0.1%	99.4 ± 0.03%	99.8 ± 0.06%	98.5 ± 0.08%	0.12 ± 0.02%	0.12 ± 0.01%	0.16 ± 0.03%
Non-HP	99.4 ± 0.1%	98.6 ± 0.1%	99.2 ± 0.1%	99.6 ± 0.1%	98.0 ± 0.1%	0.12 ± 0.03%	0.11 ± 0.01%	0.12 ± 0.02%
p value	0.7	0.6	0.7	0.7	0.4	0.7	0.6	0.2